Search for:

The word or phrase you're searching for
Within sections:

The sections you wish to include in your search

Search Results

Displaying 1 - 9 of 9 results.
Breast Implant Associated - Anaplastic Large-Cell Lymphoma (BIA - ALCL)
Breast Implant Associated - Anaplastic Large-Cell Lymphoma (BIA - ALCL), HPRA Website, - Anaplastic Large-Cell Lymphoma (BIA – ALCL) Last Updated: 27 September 2019 Background BIA-ALCL, (WHO) provisional recognition as a type of ALCL in 2016. It can be difficult to accurately explain the risk of developing rare conditions such as BIA-ALCL, but it is important that individuals, BIA-ALCL has been shown to be more common than first thought, but it still remains a rare condition
Breast Implants
implant illness'. Breast implant illness is not related to cancer or to BIA-ALCL. The HPRA has, Lymphoma (BIA-ALCL) and ‘Breast Implant Illness’. BIA-ALCL is a rare but important condition that has, -ALCL, for the public and healthcare professionals in the link below. Breast Implant Associated - Anaplastic Large-Cell Lymphoma (BIA – ALCL) Some individuals who have breast implants may, -ALCL are different conditions with different symptoms, treatment options and outcomes
Allergan Textured Breast Implants
; Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). European and International, between breast implants and this rare lymphoma. Although most cases of BIA-ALCL reported worldwide, the surface texture of implants and BIA-ALCL has not been established and the mechanism for the development of BIA-ALCL is yet to be determined. The HPRA is continuing to closely monitor and assess the issue of BIA-ALCL. For more information on BIA-ALCL, see the dedicated section of the HPRA Website
Authority Report for the meeting of 12 September 2019
. Specific points discussed included:  BIA ALCL: The Chief Executive provided an update, in the past 10 years to highlight BIA ALCL and provide advice.  Vaginal mesh: This continues
Authority Report for the meeting of 6 December 2018
and (2) ALCL. The HPRA HR and Change team were congratulated on winning Best Health and Wellbeing
Authority Report for the meeting of 2 May 2019
implants and BIA-ALCL; valproate; cannabis; and the Children and Family Act as it relates to assisted
Medical Devices Newsletter - Issue 44 - Jan 2016
device specifc taskforces: MoM, Radiotherapy and ALCL. Industry presented a paper on periodic
Public consultation on medical device fees 2021
associated anaplastic large cell lymphoma (BIA-ALCL).  We continued to focus our vigilance